Anatomical distribution of small cell lung cancer: Effects of lobe and gender on brain metastasis and survival

Anticancer Research

Volumn 25, Issue 2 A, 2005, Pages 1101-1108

  Sahmoun, Abe E ^a   Case, L Douglas ^b   Santoro, Thomas J ^a   Schwartz, Gary G ^b  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastasis; Epidemiology; Gender; Left lung; Lower lobe; Right lung; Small cell lung cancer; Smoking; Upper lobe

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; BODY MASS; BRAIN METASTASIS; CANCER LOCALIZATION; CANCER SURVIVAL; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; INCIDENCE; LEFT LUNG; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; REVIEW; RIGHT LUNG; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE;

EID: 17444383472     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Jemal A, Thomas A, Murray T et al: Cancer statistics 2004. CA Cancer J Clin 54: 8-29, 2004.
2. Kristensen CA, Jensen PB, Poulsen HS and Hansen HH: Small cell lung cancer: biological and therapeutic aspects. Crit Rev Oncol/Hematol 22: 27-60, 1996.
3. Sheehan RG: Southwestern Internal Medicine conference: Small cell lung cancer: a problem of tumor heterogeneity. Am J Med Sci 292(4): 241-256, 1986.
4. Sehested M, Hirsch FR, Osterlind K and Olsen JE: Morphologic variations of small cell lung cancer. A histopathologic study of pretreatment and posttreatment specimens in 104 patients. Cancer 57: 804-807, 1986.
5. Garland LH, Beier RL, Coulson W, Heald JH and Stein RL: The apparent sites of origin of carcinomas of the lung. Radiology 78: 1-11, 1962.
6. Spencer H: Pathology of the Lung Cancer. 3rd ed. New York: Pergamon Press, pp. 799, 1977.
7. Byers TE, Vena JE and Rzepka TF: Predilection of lung cancer for the upper lobes: an epidemiologic inquiry. J Natl Cancer Inst 72(6): 1271-1275, 1984.
8. Celikoglu SI, Aykan TB, Karayel T, Demirci S and Goksel FM: Frequency of distribution according to histological types of lung cancer in the tracheobronchial tree. Respiration 49(2): 152-156, 1986.
9. Parkash OM: Lung cancer. A statistical study based on autopsy data from 1928 to 1972. Respiration 34(5): 295-304, 1977.
10. Nugent JL, Bunn PA Jr, Matthews MJ et al: CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 44: 1885-1893, 1979.
11. Rosen S, Makuch R, Lichter A, Ihde D, Matthews M, Minna J, Glatstein E and Bunn P: Role of prophylactic cranial irradiation in prevention of CNS metastases in SCLC. Am J Med 74: 615-623, 1983.
12. Felletti R, Souhami RL, Spiro SG, Geddes DM, Tobias JS, Mantell BS, Harper PG and Trask C: Social consequences of brain or liver relapse in small cell carcinoma of the bronchus. Radiother Oncol 4(4): 335-339, 1985.
13. Postmus PE, Haaxma-Reiche H, Smit EF et al: Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy - a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 18(19): 3400-3408, 2000.
14. Auperin A, Arriagada R, Pignon J-P et al: Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. N Engl J Med 341: 476-484, 1999.
15. Glantz MJ, Choy H and Yee L: Prophylactic cranial irradiation in small cell lung cancer: rationale, results, and recommendations. Semin Oncol 24(4): 477-483, 1997.
16. World Health Organization: International Classification of Diseases. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Ninth Revision Vol. 1 Geneva: World Health Organization 1977.
17. Cox DR: Regression models and life-tables. J R Stat Soc 34B: 187-220, 1968.
18. Blot JW and McLaughin JK: Are women more susceptible to lung cancer? J Nat Cancer Inst 96(11): 812-813, 2004.
19. Fraumeni JF Jr and Blot WJ: Lung and pleura. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. Philadelphia PA: WB Saunders, pp. 564-582, 1982.
20. Higgins IT and Wynder EL: Reduction in risk of lung cancer among ex-smokers with particular reference to histologic type. Cancer 62: 2397-2401, 1988.
21. Lubin JH and Blot WJ: Assessment of lung cancer risk factors by histologic category. J Nat Cancer Inst 73: 383-389, 1984.
22. Brownson RC, Reif JS, Keefe TJ, Ferguson SW and Pritzl JA: Risk factors for adenocarcinoma of the lung. Am J Epidemiol 125: 25-34, 1987.
23. McConnell RB, Gordon KCT and Jones T: Occupational and personal factors in the aetiology of carcinoma of the lung. Lancet 2: 651-656, 1952.
24. MacLennan R, Da Costa J, Day NE et al: Risk factors for lung cancer in Singapore Chinese, a population with high female incidence rates. Int J Cancer 20: 854-860, 1977.
25. Correa P, Pickle LW, Fontham E et al: The cause of lung cancer in Louisiana. In: Mizell M, Correa P, eds. Lung Cancer: Causes and Prevention. Verlag Chemie International, pp. 73-82, 1984.
26. Lubin JH, Blot WJ, Berrino F et al: Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer 33: 569-576, 1984.
27. Humble CG, Samet JM, Pathak DR and Skipper BJ: Cigarette smoking and lung cancer in 'Hispanic' whites and other whites in New Mexico. Am J Public Health 75(2): 145-148, 1985.
28. Cohn BA, Wingard DL, Cirillo PM, Cohen RD and Kaplan GA: Is cigarette smoking a stronger risk factor for lung cancer mortality for women than for men? Evidence from a cohort study with follow-up into the 1980s. Am J Epidemiol 126: 767, 1987.
29. Schoenberg JB, Wilcox HB, Mason TJ, Bill J and Stemhagen A: Variation in smoking-related lung cancer risk among New Jersey women. Am J Epidemiol 130(4): 688-695, 1989.
30. Zang EA and Wynder EL: Differences in lung cancer risk between men and women: examination of the evidence. J Nat Cancer Inst 88: 183-192, 1996.
31. Zang EA and Wynder EL: Cumulative tar exposure. A new index for estimating lung cancer risk among cigarette smokers. Cancer 70: 69-76, 1992.
32. Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ and Miller A: Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histological type. Am J Epidemiol 138: 281-293, 1993.
33. Harris RE, Zang EA, Anderson JL and Wynder EL: Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol 22: 592-599, 1993.
34. Brownson RC, Chang JC and Davis JR: Gender and histologic type variations in smoking related risk of lung cancer. Epidemiology 3: 61-64, 1992.
35. Ryberg D, Hewer A, Phillips DH and Haugen A: Different susceptibility to smoking induced DNA damage among male and female lung cancer patients. Cancer Res 54: 5801-5803, 1994.
36. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK and Spitz MR: Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiology study. J Nat Cancer Inst 92: 1764-1772, 2000.
37. Mollerup S, Ryberg D, Hewer A, Phillips DH and Haugen A: Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 59: 3317-3320, 1999.
38. Lee Chien-Hung, Ko Chin-Ying, Cheng Shu-Chuan L et al: The heterogeneity in risk factors of lung cancer and difference of histologic distribution between genders in Taiwan. Cancer Causes Control 12: 289-300, 2001.
39. Osann KE, Anton-Culver H, Kurosaki T and Taylor T: Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer 54(1): 44-48, 1993.
40. Silverberg E: Cancer statistics, 1980. CA Cancer J Clin 30: 23, 1980.
41. Stockwell HG, Armstrong AW and Leaverton PE: Histopathology of lung cancers among smokers and nonsmokers in Florida. Int J Epidemiol 3(1): S48-S52, 1990.
42. Garland LH, Beier RL, Coulson W, Heald JH and Stein RL: The apparent sites of origin of carcinomas of the lung. Radiology 78: 1-11, 1962.
43. Lulu DJ and Lawson LJ: Carcinoma of the lung: A review of 321 cases. Arch Surg 88: 213-217, 1964.
44. Hiraoka K, Horie A and Kido M: Study of asbestos bodies in Japanese urban patients. Am J Ind Med 18(5): 547-554, 1990.
45. Meyer EC and Liebow AA: Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung. Cancer 75: 322-351, 1965.
46. Schlesinger RB and Lippmann M: Particle deposition in casts of the human upper tracheobronchial tree. Am Ind Hyg Assoc J 33(4): 237-251, 1972.
47. Fisher W: Der Lungenkrebs. Zentbl. Allg. Path Anat 85: 193-212, 1949.
48. Waldeyer A: Anatomie des Menschen. II. Teil, Gruyter, pp. 461-462, 1950.
49. Johnson FC: Carcinogenesis, vascular disease, and the free radical reaction. Nutr Cancer 3(3): 117-121, 1982.
50. Burton AC: Cancer and altitude. Does intracellular pH regulate cell division? Eur J Cancer 11(5): 365-371, 1975.
51. Gazdar AF and Minna JD: Cigarettes, sex, and lung cancer adenocarcinoma. J Nat Cancer Inst 89: 1563-1565, 1997.
52. Carbone D: Smoking and cancer. Am J Med 93: 13S-17S, 1992.
53. Doll R and Peto R: Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Commun Health 32: 303-313, 1978.
54. Sagman U, Maki E, Evans WK et al: Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol 9(9): 1639-1649, 1991.
55. Albain KS, Crowley JJ, LeBlanc M and Livingston RB: Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol 8(9): 1563-1574, 1990.
56. Wolf M, Holle R, Hans K, Drings P and Havemann K: Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival. Br J Cancer 63(6): 986-992, 1991.
57. Souhami RL, Bradbury I, Geddes DM, Spiro SG, Harper PG and Tobias JS: Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res 45(6): 2878-2882, 1985.
58. Rawson NS and Peto J: An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. Br J Cancer 61(4): 597-604, 1990.
59. Osterlind K and Andersen PK: Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 46(8): 4189-4194, 1986.
60. Maurer LH and Pajak TF: Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study. Cancer Treat Rep 65(9-10): 767-774, 1981.
61. Sheehan RG, Balaban EP, Cox JV and Frenkel EP: The relative value of conventional staging procedures for developing prognostic models in extensive-stage small-cell lung cancer. J Clin Oncol 8(12): 2047-2053, 1990.
62. Praire AE, Johnson EH, Yesner R, Zhang XB, Spjut HJ and Greenberg SD: Prognostic significance of histopathologic subtype and stage in small cell lung cancer. Hum Pathol 23(5): 520-528, 1992.
63. Fraire AE, Johnson EH, Yesner R, Zhang XB, Spjut HJ and Greenberg SD: Prognostic significance of histopathologic subtype and stage in small cell lung cancer. Hum Pathol 23(5): 520-528, 1992.
64. Greenberg ER, Korson R, Baker J et al: Incidence of lung cancer by type: a population-based study in New Hampshire and Vermont. J Nat Cancer Inst 72(3): 599-603, 1984.
65. Ries LA: Influence of extent of disease, histology, and demographics factors on lung cancer survival in the SEER population-based data. Semin Surg Oncol 10: 21-30, 1994.
66. Stahel RA and Weber E: Small cell lung cancer: the new biology. Semin Rad Oncol 5(1): 11-18, 1995.
67. Spiegelman D, Maurer LH, Ware JH et al: Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients. J Clin Oncol 7(3): 344-354, 1989.
68. Skarin AT: Analysis of long-term survivors with small-cell lung cancer. Chest 103: 440S, 1993.
69. Shepherd FA, Ginsberg RJ, Haddad R et al: Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group. J Clin Oncol 11(8): 1592-1597, 1993.
70. Ouellette D, Desbiens G, Emond C and Beauchamp G: Lung cancer in women compared with men: stage, treatment, and survival. Ann Thorac Surg 66: 1140-1144, 1998.
71. Giannone L, Johnson DH, Hande KR et al: Favorable prognosis of brain metastases in small cell lung cancer. Ann Intern Med 106: 386-389, 1987.
72. Hagerdorn HE, Haaxma-Reiche H, Canrinus AA et al: Results of whole brain radiotherapy for brain metastases of small cell lung cancer. Lung Cancer 5: 293-300, 1993.
73. Pladdet I, Boven E, Nauta J and Pinedo HM: Palliative care for brain metastases of solid tumour types. Neth J Med 34(1-2): 10-21, 1989.
74. Suissa S, Pollak M, Spitzer W et al: Body size and breast cancer prognosis: a statistical explanation of the discrepancies. Cancer Res 49: 3113-3116, 1989.
75. Senie RT, Rosen PP, Rhodes P et al: Obesity at diagnosis of breast carcinoma influences duration of disease free-survival. Ann Intern Med 116: 26-32, 1992.
76. Bastarrachea J, Hortobagyi GN, Smith TL et al: Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med 119: 18-25, 1994.
77. Tarella C, Caracciolo D, Gavarotti P et al: Overweight as an adverse prognostic factor for NHL patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant 26(11): 1185-1191, 2000.
78. Georgiadis MS, Steinberg SM, Hankins LA, Ihde DC and Johnson BE: Obesity and therapy-related toxicity in patients treated for small-cell lung cancer. J Nat Cancer Inst 87(5): 361-366, 1995.